140 related articles for article (PubMed ID: 15153359)
1. [Contribution of the scintigraphy with iodocholesterol (I-COL) to the diagnosis and characterization of silent adrenal masses].
Rodado Marina S; Aguirre Sánchez-Covisa M; García Vicente AM; Poblete García VM; Ruiz Solís S; Cortés Romera M; Soriano Castrejón A
Rev Esp Med Nucl; 2004; 23(3):166-73. PubMed ID: 15153359
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing benign from malignant euadrenal masses.
Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
[TBL] [Abstract][Full Text] [Related]
3. The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxtaadrenal masses.
Nakajo M; Nakabeppu Y; Yonekura R; Iwashita S; Goto T
Ann Nucl Med; 1993 Aug; 7(3):157-66. PubMed ID: 8217490
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
Maurea S; Klain M; Mainolfi C; Ziviello M; Salvatore M
J Nucl Med; 2001 Jun; 42(6):884-92. PubMed ID: 11390552
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy.
Kloos RT; Gross MD; Shapiro B; Francis IR; Korobkin M; Thompson NW
World J Surg; 1997 Jan; 21(1):36-40. PubMed ID: 8943175
[TBL] [Abstract][Full Text] [Related]
6. [Contribution of nuclear medicine to the diagnosis of silent adrenal masses].
Rufini V; Troncone L; Daidone MS; Corsello SM; Danza FM
Radiol Med; 1994 Mar; 87(3):319-26. PubMed ID: 8146373
[TBL] [Abstract][Full Text] [Related]
7. [Adrenal gland scintigraphy].
Fischer M; Vetter H
Radiologe; 1986 Apr; 26(4):181-5. PubMed ID: 3012627
[TBL] [Abstract][Full Text] [Related]
8. Quantitative imaging characterization of hypersecreting or nonhypersecreting adrenal adenomas: comparison between iodine-131 norcholesterol uptake and magnetic resonance signal intensity ratios.
Maurea S; Imbriaco M; Mollica C; Pace L; Salvatore M
Nucl Med Commun; 2011 Jun; 32(6):535-41. PubMed ID: 21448089
[TBL] [Abstract][Full Text] [Related]
9. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
10. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the large adrenal mass.
Khafagi FA; Gross MD; Shapiro B; Glazer GM; Francis I; Thompson NW
Br J Surg; 1991 Jul; 78(7):828-33. PubMed ID: 1873713
[TBL] [Abstract][Full Text] [Related]
12. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
Taillefer R; Soucy JP; Eybalin MC; Levasseur A
J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
[TBL] [Abstract][Full Text] [Related]
13. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
14. Sixty adrenal masses of large dimensions: hormonal and morphologic evaluation.
Bernini GP; Miccoli P; Moretti A; Vivaldi MS; Iacconi P; Salvetti A
Urology; 1998 Jun; 51(6):920-5. PubMed ID: 9609627
[TBL] [Abstract][Full Text] [Related]
15. SPECT semiquantitative analysis of adrenocortical (131)I-6 beta iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma.
La Cava G; Imperiale A; Olianti C; Gheri GR; Ladu C; Mannelli M; Pupi A
J Nucl Med; 2003 Jul; 44(7):1057-64. PubMed ID: 12843220
[TBL] [Abstract][Full Text] [Related]
16. Incidentally discovered adrenal masses.
Kloos RT; Gross MD; Francis IR; Korobkin M; Shapiro B
Endocr Rev; 1995 Aug; 16(4):460-84. PubMed ID: 8521790
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of iodine-131-iodocholesterol in renal cell carcinoma adrenal metastases.
Tsukamoto E; Itoh K; Kanegae K; Kobayashi S; Koyanagi T; Tamaki N
J Nucl Med; 1998 Apr; 39(4):656-8. PubMed ID: 9544676
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol.
Reschini E; Catania A
Eur J Nucl Med; 1991; 18(10):817-23. PubMed ID: 1743205
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of iodine-131 6beta-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism.
Nocaudie-Calzada M; Huglo D; Lambert M; Ernst O; Proye C; Wemeau JL; Marchandise X
Eur J Nucl Med; 1999 Oct; 26(10):1326-32. PubMed ID: 10541832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
